BI 1356, high dose
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers
CompletedNCT02173652
Start: 2008-03-31Updated: 2014-07-08
Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects
CompletedNCT02183467
Start: 2008-01-31Updated: 2014-07-08